HPV-related cancer vaccine (Dana-Farber)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHPV-related cancer vaccine (Dana-Farber)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer Institute
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A